Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

[Finding the right platelet anti-aggregant prescription for type-2 diabetes patients, according to the ADA 2003 criteria]

Sandra Raméntol Teys, Vicenta Pujol Blaya, Mónica León de la Fuente, María León-Sanromà

Atencion Primaria 2006 October 31, 38 (7): 413

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

[Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA?]. Carmen Maciá Bobes, Aránzazu Ronzón Fernández, Elisa Fernández García Atencion Primaria 2007, 39 (3): 163-4

Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital. Alberto Bruno, Giorgio Grassi, Franco Dani, Mariella Degiovanni, Giorgio Maghenzani, Gianfranco Pagano Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2005, 15 (1): 42-6

[Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease]. M M C Hovens, S C Cannegieter Nederlands Tijdschrift Voor Geneeskunde 2004 October 16, 148 (42): 2097; author reply 2097-8

Does aspirin use reduce cardiovascular risk in diabetes? John A Colwell Nature Reviews. Endocrinology 2009, 5 (4): 188-90

Aspirin therapy is still underutilized among patients with type 2 diabetes. Cristiane B Leitão, Ana L Krahe, Gustavo B Nabinger, Paula X Picon, Miriam Pecis, Lérida M Zaslavsky, Jorge L Gross, Luis H Canani Arquivos Brasileiros de Endocrinologia e Metabologia 2006, 50 (6): 1014-9

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question. Antonio Nicolucci JAMA 2008 November 12, 300 (18): 2180-1

[Use of aspirin for primary prevention of cardiovascular events in diabetic patients--is it justified?]. Y Benhamou, H Lévesque La Revue de Médecine Interne 2009, 30 (12): 1001-3

Aspirin in the treatment of type 2 diabetes. S K Kajubi Archives of Internal Medicine 2000 February 14, 160 (3): 394

Appropriate aspirin use for primary prevention of cardiovascular disease. W Fred Miser American Family Physician 2011 June 15, 83 (12): 1380-6

Aspirin for primary prevention of cardiovascular events in people with diabetes. Michael Pignone, Mark J Alberts, John A Colwell, Mary Cushman, Silvio E Inzucchi, Debabrata Mukherjee, Robert S Rosenson, Craig D Williams, Peter W Wilson, M Sue Kirkman Journal of the American College of Cardiology 2010 June 22, 55 (25): 2878-86

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

[Finding the right platelet anti-aggregant prescription for type-2 diabetes patients, according to the ADA 2003 criteria]

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips